{"id":"W2404165994","doi":"10.1016/j.jval.2016.03.1536","title":"Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer: Systematic Review and Trial Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Surrogate endpoint; Progression-free survival; Rank correlation; Breast cancer; Spearman's rank correlation coefficient; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Meta-analysis; Proportional hazards model; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Statistics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02345765,0.003264986,0.01887788,0.002553121,0.0005187196,0.003280388,0.002441283,0.002736883,0.002810515],"category_scores_gemma":[0.0490889,0.001748111,0.04421614,0.003224976,0.001070583,0.002402326,0.001960666,0.003747745,0.0003444093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002109981,"about_ca_system_score_gemma":0.001791067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003788131,"about_ca_topic_score_gemma":0.009991609,"domain_scores_codex":[0.9781376,0.01391277,0.004049394,0.002136024,0.001385384,0.0003787904],"domain_scores_gemma":[0.9728664,0.01997104,0.004066943,0.00176022,0.001026095,0.0003091028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004252129,0.00001422403,0.002693379,0.0514743,0.9374207,0.0000374696,0.00003337602,0.0003604256,0.0001229003,0.00007444233,0.000207844,0.003308734],"study_design_scores_gemma":[0.001585221,0.0003055562,0.001831279,0.002176753,0.9930335,0.00004588738,0.0000174058,0.0002289748,0.00007384046,0.0002037772,0.000481017,0.0000167866],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02370415,0.970289,0.003147703,0.0003622253,0.0005400875,0.0004217014,0.0008854414,0.0001002299,0.0005494696],"genre_scores_gemma":[0.7458407,0.242579,0.005897227,0.002088134,0.000581488,0.001029796,0.001190057,0.0001290334,0.0006646254],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9811221,"threshold_uncertainty_score":0.1240575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3443622585164965,"score_gpt":0.4873158821782045,"score_spread":0.142953623661708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}